Less than a day remains until Oct. 17.
The sun's going to rise on a different world tomorrow, one in which medical and – importantly – recreational marijuana will be freely available for purchase and use by consenting Canadian adults from the Yukon to Newfoundland.
Investors have even more to look forward to.
The latest analyst estimates (they're consistently being revised upward) could hardly be more bullish.
Research firm Deloitte expects – once you consider the growers, the value-added product makers, the testing labs, security, tourism, exports, and all the rest – the Canadian legal cannabis market soon could reach an eye-watering $22.6 billion.
And even at this late hour, there are still some must-own stocks that American investors can buy – easily, I'd add – to leverage this historic moneymaking opportunity.